Immunologic and tumor responses of pegilodecakin with 5-FU/LV and oxaliplatin (FOLFOX) in pancreatic ductal adenocarcinoma (PDAC).
Hecht JR, Papadopoulos KP, Falchook GS, Patel MR, Infante JR, Aljumaily R, Wong DJ, Autio KA, Wainberg ZA, Bauer TM, Javle M, Pant S, Bendell J, Hung A, Ratti N, VanVlasselaer P, Verma R, Leveque J, Rao S, Oft M, Naing A.
Hecht JR, et al.
Invest New Drugs. 2021 Feb;39(1):182-192. doi: 10.1007/s10637-020-01000-6. Epub 2020 Sep 10.
Invest New Drugs. 2021.
PMID: 32910338
Free PMC article.
Clinical Trial.